NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-052-1994-0-JP-05 VECTOR SYSTEMS FOR THE GENERATION OF ADENO-ASSOCIATED VIRUS PARTICLES JP National Stage 1995-515208 Abandoned
NHLBI E-052-1994-0-EP-04 VECTOR SYSTEMS FOR THE GENERATION OF ADENO-ASSOCIATED VIRUS PARTICLES EP National Stage 95904118.7 Abandoned
NHLBI E-052-1994-0-CA-03 VECTOR SYSTEMS FOR THE GENERATION OF ADENO-ASSOCIATED VIRUS PARTICLES CA National Stage 2176600 Abandoned
NCI E-046-1991-5-US-01 A METHOD OF PRODUCING HEPATOCYTE GROWTH FACTOR/SCATTOR FACTOR AND RELATED CELL LINES US CIP 08/344,710 5871959 Expired PDF
NHLBI E-013-1990-2-US-02 Novel Retroviral Vectors US FWC 08/340,805 5672510 Expired PDF
NHLBI E-286-1988-3-US-02 PARVOVIRUS CAPSIDS US FWC 08/341,264 Abandoned
NCI E-011-1994-0-EP-05 Method and Composition for Transfer of Active Tumor-Specific Immunization From an Immunized Allogeneic Bone Marrow Donor EP National Stage 95903544.5 Abandoned
NCI E-011-1994-0-IE-07 Method and Composition for Transfer of Active Tumor-Specific Immunization From an Immunized Allogeneic Bone Marrow Donor IE EP 95903544.5 Abandoned
NCI E-011-1994-0-CA-03 Method and Composition for Transfer of Active Tumor-Specific Immunization From an Immunized Allogeneic Bone Marrow Donor CA National Stage 2176738 Abandoned
NCI E-011-1994-0-AU-04 Method and Composition for Transfer of Active Tumor-Specific Immunization From an Immunized Allogeneic Bone Marrow Donor AU National Stage 12564/95 Abandoned
NCI E-139-1994-0-US-01 METHOD OF MOBILIZING PLURIPOTENTIAL HEMATOPOIETIC STEM CELLS WITH IL-7 US ORD 08/341,399 5637323 Expired PDF
NCI E-011-1994-0-PCT-02 METHOD AND COMPOSITION FOR TRANSFER OF ACTIVE TUMOR-SPECIFIC IMMUNIZATION FROM AN IMMUNIZED ALLOGENIC BONE MARROW DONOR PCT PCT PCT/US1994/013224 Expired
NCI E-011-1994-0-JP-06 Method and Composition for Transfer of Active Tumor-Specific Immunization From an Immunized Allogeneic Bone Marrow Donor JP National Stage 7-514584 Abandoned
NEI E-173-1994-0-US-01 METHODS FOR INHIBITING CELL PROLIFERATION BY INHIBITING THE MITOGENIC ACTIVITY OF MACROPHAGE MIGRATION INHIBITORY FACTOR US ORD 08/340,826 Abandoned
NCI E-136-1993-0-US-13 PULSED LOW FREQUENCY EPR SPECTROMETER AND IMAGER US CON 08/340,100 5502386 Expired PDF
NIA E-180-1992-0-US-03 TARGETING OF LIPOSOMES TO THE BLOOD-BRAIN BARRIER US CON 08/338,939 Abandoned
NCI E-027-1990-0-US-03 CLONED HUMAN CRIPTO GENE AND APPLICATIONS THEREOF US FWC 08/337,911 5654140 Expired PDF
NCI E-196-1991-0-US-07 A METHOD FOR TREATING KAPOSI'S SARCOMA AND BLOCKING OR INHIBITING VASCULAR PERMEABILITY US CON 08/336,612 5518999 Expired PDF
NIAID E-220-1988-0-US-04 CYTOTOXIC AGENT AGAINST SPECIFIC VIRUS INFECTION US FWC 08/335,669 5587455 Expired PDF
NIDDK E-121-1993-0-US-03 8-SUBSTITUTED 1,3,7-TRIALKYL-XANTHINE DERIVATIVES US FWC 08/335,108 5861405 Expired PDF
NIDDK E-072-1990-2-US-03 Nitrogen containing cyclohetero cycloalklyaminoaryl derivatives for CNS-disorders US CON 08/335,532 Abandoned
NCI E-235-1993-0-EP-21 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY EP National Stage 95900491.2 Abandoned
NCI E-235-1993-0-LU-13 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY LU EP 95900491.2 Abandoned
NCI E-235-1993-0-BE-09 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY BE EP 95900491.2 Abandoned
NCI E-235-1993-0-AT-04 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY AT EP 95900491.2 Abandoned
NCI E-235-1993-0-DK-11 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY DK EP 95900491.2 Abandoned
NCI E-235-1993-0-GB-22 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY GB EP 95900491.2 Abandoned
NCI E-235-1993-0-CH-05 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY CH EP 95900491.2 Abandoned
NCI E-235-1993-0-SE-08 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY SE EP 95900491.2 Abandoned
NCI E-235-1993-0-IE-12 USE OF NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY IE EP 95900491.2 Abandoned
NCI E-235-1993-0-GR-16 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY GR EP 3034099 Abandoned
NCI E-235-1993-0-IT-07 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY IT EP 95900491.2 Abandoned
NCI E-235-1993-0-FR-17 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY FR EP 95900491.2 Abandoned
NCI E-235-1993-0-DE-20 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY DE EP 95900491.2 Abandoned
NCI E-235-1993-0-NL-10 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY NL EP 95900491.2 Abandoned
NCI E-235-1993-0-ES-06 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY ES EP 95900491.2 Abandoned
NCI E-235-1993-0-PT-15 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY PT EP 95900491.2 Abandoned
NCI E-235-1993-0-MC-14 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY MC EP 95900491.2 Abandoned
NCI E-235-1993-0-AU-18 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY AU National Stage 81300/94 Abandoned
NCI E-235-1993-0-PCT-02 USE OF NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY PCT PCT PCT/US1994/012510 Abandoned
NCI E-235-1993-0-JP-23 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY JP National Stage 1995-513345 Abandoned
NCI E-235-1993-0-CA-19 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY CA National Stage 2175467 Abandoned
NHLBI E-156-1992-0-US-05 EXPRESSION OF HUMAN MULTIDRUG RESISTANCE GENES AND SELECTION OF CELLS TRANSDUCED WITH SUCH GENES US FWC 08/332,444 Abandoned
NCI E-147-1991-2-US-01 CHIMERIC AND MUTATIONALLY STABILIZED TUMOR-SPECIFIC ANTIBODY FRAGMENT FUSION PROTEINS, AND USES THEREOF US CIP 08/331,397 5981726 Abandoned PDF
NCI E-147-1991-1-US-01 HUMANIZED TUMOR-SPECIFIC ANTIBODY FRAGMENTS, FUSION PROTEINS, AND USES THEREOF US CIP 08/331,396 5889157 Abandoned PDF
NCI E-147-1991-3-US-01 SINGLE CHAIN B3 ANTIBODY FUSION PROTEINS AND THEIR USES US CIP 08/331,398 5608039 Abandoned PDF
NCI E-208-1992-0-CA-04 DEVELOPMENT OF A VECTOR TO TARGET GENE EXPRESSION TO THE EPIDERMIS OF TRANSCENIC ANIMALS CA National Stage 2134675 Abandoned
NCI E-132-1988-0-US-05 Use of 8-C1-cAMP as Anticancer Drug US FWC 08/329,764 5792752 Abandoned PDF
NCI E-151-2007-0-FR-01 Nucleotide Sequences Of HIV-1 Type (or Subtype) O Retrovirus Antigens FR ORD 94/12554 Expired
NIAID E-123-1992-3-US-01 ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE COMPOSITIONS US CIP 08/327,263 5922326 Expired PDF